Sulfamethoxazole and Trimethoprim (RedPharm Drug, Inc.)


Welcome to the PulseAid listing for the Sulfamethoxazole and Trimethoprim drug offered from RedPharm Drug, Inc.. This Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA],Sulfonamide Antimicrobial [EPC],Sulfonamides [Chemical/Ingredient],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: RedPharm Drug, Inc.
NON-PROPRIETARY NAME: Sulfamethoxazole and Trimethoprim
SUBSTANCE NAME: TRIMETHOPRIM; SULFAMETHOXAZOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA],Sulfonamide Antimicrobial [EPC],Sulfonamides [Chemical/Ingredient],Cytochrome P450 2C9 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2010-01-01
END MARKETING DATE: 0000-00-00


Sulfamethoxazole and Trimethoprim HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSulfamethoxazole and Trimethoprim from RedPharm Drug, Inc.
LABELER NAME: RedPharm Drug, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 160; 800(mg/1; mg/1)
START MARKETING DATE: 2010-01-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67296-0227_3fc95839-6b78-1303-e054-00144ff88e88
PRODUCT NDC: 67296-0227
APPLICATION NUMBER: ANDA076899

Other TRIMETHOPRIM; SULFAMETHOXAZOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
RedPharm Drug, Inc.Sulfamethoxazole and Trimethoprim